Efficacy and safety of ‘Second Adjuvant’ therapy with BRAF/MEK inhibitors after local therapy for recurrent melanoma following adjuvant PD-1 based immunotherapy
Titel:
Efficacy and safety of ‘Second Adjuvant’ therapy with BRAF/MEK inhibitors after local therapy for recurrent melanoma following adjuvant PD-1 based immunotherapy
Auteur:
Taylor, Amelia M. McKeown, Janet Dimitriou, Florentia Jacques, Sarah K. Zimmer, Lisa Allayous, Clara Yeoh, Hui-Ling Haydon, Andrew Ressler, Julia M. Galea, Claire Woodford, Rachel Kahler, Katharina Hauschild, Axel Festino, Lucia Hoeller, Christoph Schwarze, Julia K. Neyns, Bart Wicky, Alexandre Michielin, Olivier Placzke, Joanna Rutkowski, Piotr Johnson, Douglas B. Lebbe, Celeste Dummer, Reinhard Ascierto, Paolo A. Lo, Serigne Long, Georgina V. Carlino, Matteo S. Menzies, Alexander M.